Kinnate Biopharma (KNTE) Insider Trading & Ownership → A new way to collect income from stocks (From DTI) (Ad) Free KNTE Stock Alerts $2.65 -0.01 (-0.38%) (As of 04/3/2024) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Kinnate Biopharma (NASDAQ:KNTE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage41.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$9.07 MNumber OfInsiders Selling(Last 12 Months)0 Get KNTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Kinnate Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KNTE Insider Buying and Selling by Quarter Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << Kinnate Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/8/2023James B TananbaumDirectorBuy1,780,000$2.80$4,984,000.00 5/4/2023Orbimed Advisors LlcDirectorBuy479,909$2.75$1,319,749.75 5/1/2023Carl L GordonDirectorBuy716,157$2.62$1,876,331.34 4/28/2023Carl L GordonDirectorBuy350,749$2.55$894,409.95 (Data available from 1/1/2013 forward) KNTE Insider Trading Activity - Frequently Asked Questions Who is on Kinnate Biopharma's Insider Roster? The list of insiders at Kinnate Biopharma includes Carl L Gordon, James B Tananbaum, Orbimed Advisors Llc, and Richard Thomas Williams. Learn more on insiders at KNTE. What percentage of Kinnate Biopharma stock is owned by insiders? 41.70% of Kinnate Biopharma stock is owned by insiders. Learn more on KNTE's insider holdings. Which Kinnate Biopharma insiders have been buying company stock? The following insiders have purchased KNTE shares in the last 24 months: Carl L Gordon ($2,770,741.29), James B Tananbaum ($4,984,000.00), and Orbimed Advisors Llc ($1,319,749.75). How much insider buying is happening at Kinnate Biopharma? Insiders have purchased a total of 3,326,815 KNTE shares in the last 24 months for a total of $9,074,491.04 bought. More Insider Trading Tools from MarketBeat Related Companies: NGM Biopharmaceuticals Insider Selling Assembly Biosciences Insider Selling vTv Therapeutics Insider Selling Theseus Pharmaceuticals Insider Selling AVROBIO Insider Selling SAB Biotherapeutics Insider Selling Merrimack Pharmaceuticals Insider Selling Brainstorm Cell Therapeutics Insider Selling Acrivon Therapeutics Insider Selling LianBio Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:KNTE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kinnate Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
